Exelixis (EXEL)
(Delayed Data from NSDQ)
$39.14 USD
+0.13 (0.33%)
Updated Sep 16, 2025 04:00 PM ET
After-Market: $39.14 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth C Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
EXEL 39.14 +0.13(0.33%)
Will EXEL be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for EXEL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for EXEL
Here's Why Exelixis (EXEL) is a Strong Momentum Stock
Do Options Traders Know Something About Exelixis Stock We Don't?
EXEL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Why Is Alkermes (ALKS) Up 4.7% Since Last Earnings Report?
Why Is Exelixis (EXEL) Up 3.8% Since Last Earnings Report?
Can Label Expansion of Cabometyx Fuel Further Growth for EXEL?
Other News for EXEL
Exelixis price target raised by $4 at Morgan Stanley, here's why
Exelixis initiated with a Buy at Goldman Sachs
Exelixis initiated with bullish view at Goldman Sachs, here's why
Technical picture remains unchanged for EXEL after it falls 0.36% on September 15
Exelixis assumed with an Equal Weight at Barclays